Stimcell Energetics Inc 's

The company operates in the competitive markets of diabetes management and pain management treatments. Its eBalance® Pro and eBalance® Home Systems utilize microcurrent therapy, a method not yet widely accepted in traditional medicine, resulting in no clearly defined direct competitors. Indirect competition includes pharmaceutical companies producing drugs for diabetes complications, manufacturers of glucose monitoring devices, and producers of pharmaceuticals for various diseases and symptoms. The company also faces competition from firms developing and commercializing electrical and microcurrent therapy technologies for acute, chronic, and postoperative pain treatment. The company's eBalance® Technology is not patented. Named competitors include BodiHealth Systems and Electromedical Products International, Inc.